Otonomy.Are REGAIN and Frequency Therapeutics the two companies leading the way to cure hearing loss or are there others to keep an eye on also?
Otonomy.Are REGAIN and Frequency Therapeutics the two companies leading the way to cure hearing loss or are there others to keep an eye on also?
Better slow than nothing.... And I really hope for a breakthrough! I want to be able to hear!This, like everything else, is moving too slowly.
Me too. Being able to hear music again would be the most joyful moment in my life.Better slow than nothing.... And I really hope for a breakthrough! I want to be able to hear!
Phase 2 has not started yet but when it does they will announce it.Do you reckon Frequency Therapeutics have started their Phase 2 trials yet?
Fun fact: there are 43 companies currently working on hearing restoration drugs right nowHaving REGAIN, Frequency Therapeutics and Otonomy all working on cures are a lot more options than we had just a few years ago. I personally did the LLLT for 2 years. Although it calmed down my tinnitus, it never helped me regain my hearing loss. I'm keeping my eye on these 3.
I just would think that considering how many vets there are with tinnitus/hearing loss that the ATA would be working with the government to pour a lot of money into this instead of treating it like any other pharma company making any other drug. Considering that the ATA's head, LaGuinn Sherlock, was a research audiologist with the U.S. Army Public Health Center you'd think something like that would be happening.Better slow than nothing.... And I really hope for a breakthrough! I want to be able to hear!
You'd think wrong. LaGuinn Sherlock believes everyone will habituate and there's no need for drug treatments. She's a disgrace in my book!Considering that the ATA's head, LaGuinn Sherlock, was a research audiologist with the U.S. Army Public Health Center you'd think something like that would be happening.
43 companies?? Please list them.Fun fact: there are 43 companies currently working on hearing restoration drugs right now
It would be good to have hearing restored but my prayers go to them finding a tinnitus cure.If we do get rid of our tinnitus
I see what you mean. Sounds like a wasted position and money. Our goal is to habituate! We pray for researchers to find a cure!LaGuinn Sherlock believes everyone will habituate and there's no need for drug treatments.
You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.My opinion is that, in terms of practical treatment we should mostly keep our eyes on Regain. They are moving much faster than Frequency. They will be done with phase 2 by the end of the year, that's a massive progress. So our best bet to having a cure in a year or two is Regain. Forget Frequency, they're a toast if Regain proves to have have a functioning cure in the Phase 2.
I don't have them in list format at the moment but when I get a chance I will do some organizing and post them here.43 companies?? Please list them.
Well, I think that we have to wait and see... I am optimistic about both of them, but especially so about FX-322. Don't ask why, but it sounds bit better... ;-) but hey, the more research we have, the better it is, or? BTW: Cocktails are nice ;-)You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.
How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
I don't care, no matter what kind of improvement, everyone will throw their money at REGAIN if they release their treatment first, even if it doesn't recover hearing fully but only partially. Those lame asses at Frequency Therapeutics will make $0 if they keep with this pace of progress.You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.
How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
Here is a link to Action on Hearing loss. If you read through it there is a link to a spreadsheet of all the companies doing all sorts... hope it helps43 companies?? Please list them.
Thank you That's a good site! Well, so let's hope! I think that in the near future we will have the cure!Here is a link to Action on Hearing loss. If you read through it there is a link to a spreadsheet of all the companies doing all sorts... hope it helps
https://www.actiononhearingloss.org...log/treatments-for-hearing-loss-and-tinnitus/
They have all had to sign NDAs (non-disclosure agreements).I'm hoping that we get to hear from the people involved in the trials. I'd like for them to explain in their own words what the results were and how the drugs made them feel.
You can't keep that a secret, people talk.They have all had to sign NDAs (non-disclosure agreements).
They've done a pretty good job so far. As these trials get bigger that has to get harder though.You can't keep that a secret, people talk.
How does fast tracking work? After they are done with Phase 2 and if it's successful, how fast - after Phase 3 is done - can they release the drug to the market?They've done a pretty good job so far. As these trials get bigger that has to get harder though.
Well, as far as I have understood, Frequency Therapeutics had only patients with massive hearing loss in their trial, whereas REGAIN tested their drug in people with mild to moderate hearing loss. That's a difference of the research/treatment... Or do I interpret it wrong?You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.
How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
Just did some research and you're right. I really hope these companies actually do really well in Phase 2 and 3 and they actually do work in curing tinnitus or reducing it a lot. I don't want this to be another AM-101.Well, as far as I have understood, Frequency Therapeutics had only patients with massive hearing loss in their trial, whereas REGAIN tested their drug in people with mild to moderate hearing loss. That's a difference of the research/treatment... Or do I interpret it wrong?
I love hearing this!Someone posted this on Reddit:
I worked on this clinical trial!! This makes me so happy to see the excitement. I don't really know how much I can say as far as results/patient testimony, but it was the best study I have ever worked on. So rewarding and a great great company!
What is the likelihood that they will mention that this drug actually reduced or cured their tinnitus at the September event?